Data on five single-nucleotide polymorphisms (SNPs) per gene are estimated
to allow association of disease risks or pharmacogenetic parameters with in
dividual genes(1). Efficient technologies for rapidly detecting SNPs will t
herefore facilitate the mining of genomic information(2). Known methods for
SNP analysis include restriction-fragment-length polymorphism polymerase c
hain reaction (PCR), allele-specific oligomer hybridization, oligomer-speci
fic ligation assays, minisequencing, direct sequencing, fluorescence-detect
ed 5'-exonuclease assays, and hybridization with PNA probes(3-6). Detection
by mass spectrometry (MS) offers speed and high resolution(7,8). Matrix-as
sisted laser desorption/ionization rime-of-flight mass spectrometry (MALDI
TOF MS) can detect primer extension products(9-11), mass-tagged oligonucleo
tides(12), DNA created by restriction endonuclease cleavage(13), and genomi
c DNA(14). We have previously reported MALDI-TOF-monitored nuclease selecti
ons of modified oligonudeotides with increased affinity for targets(15). He
re we use nuclease selections for genotyping by treating DNA to be analyzed
with oligonucleotide probes representing known genotypes and digesting pro
bes that are not complementary to the DNA. With phosphodiesterase I, the ta
rget-bound, complementary probe is largely refractory to nuclease attack an
d its peak persists in mass spectra (Fig. 1A). In optimized assays, both al
leles of a heterozygote were genotyped with six nonamer DNA probes (greater
than or equal to 125 fmol each) and asymmetrically amplified DNA from exon
10 of the cystic fibrosis transmembrane regulatory gene (CFTR).